Imperva (IMPV) PT Lowered to $47 at Stifel; Remains Sidelined

November 9, 2017 8:11 AM EST Send to a Friend
Stifel lowered its price target on Imperva (NASDAQ: IMPV) to $47.00 (from $50.00) while maintaining a Hold rating following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login